Drug-loaded thermochromic soluble microneedle for moxibustion treatment as well as preparation and application of drug-loaded thermochromic soluble microneedle

By preparing drug-loaded thermochromic soluble microneedles, the problems of slow onset of action and inability to monitor temperature in moxibustion treatment have been solved, achieving efficient drug delivery and real-time temperature monitoring, thus improving the safety and efficacy of moxibustion treatment.

CN118975974APending Publication Date: 2024-11-19CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411081871.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Moxibustion treatment is slow to take effect and the skin temperature cannot be displayed, so there is no warning of the moxibustion temperature and there is a risk of burns.

Method used

A drug-loaded thermochromic soluble microneedle was prepared by combining a thermochromic dye and a hyaluronic acid solution. This soluble microneedle is used for drug delivery and temperature monitoring, and provides real-time temperature alerts through color changes.

Benefits of technology

It achieves efficient drug delivery and real-time temperature monitoring, avoiding burns and improving the safety and effectiveness of moxibustion treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118975974A_ABST
    Figure CN118975974A_ABST
Patent Text Reader

Abstract

The invention provides a drug-loaded thermochromic soluble microneedle for moxibustion treatment and preparation and application thereof. A preparation method of the drug-loaded thermochromic soluble microneedle comprises the following steps: (1) preparing a microneedle mold; (2) preparing a soluble polymer polyvinylpyrrolidone solution containing a thermochromic dye; (3) preparing a tanshinone-loaded hyaluronic acid solution; and (4) filling the tanshinone-loaded hyaluronic acid solution into a needle tip of a mold, then filling the backing part with a soluble polymer solution containing a thermochromic dye, drying, and stripping the mold to obtain the drug-loaded thermochromic soluble microneedle. The tanshinone-loaded hyaluronic acid solution serves as a needle tip part and is used for efficiently delivering drugs, and the soluble polymer solution containing the thermochromic dye serves as a backing material and can monitor the temperature of the skin surface of a moxibustion acupoint. By combining the thermochromic material and the medicine-carrying soluble microneedle, the effects of warning the moxibustion temperature, protecting tissues and preventing heat damage are achieved during moxibustion treatment; micro channels are formed in the skin through the micro needles, medicine permeation is enhanced, meanwhile, moxibustion heat is guided to permeate inwards, the moxibustion feeling is improved, and therefore the treatment effect of moxibustion is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedical materials, and in particular relates to a drug-loaded thermochromic soluble microneedle for moxibustion treatment, and a preparation method and application thereof. Background Art

[0002] Moxibustion is a traditional Chinese medicine treatment method that uses the heat generated by burning moxa sticks or moxa cones made of wormwood to warm and stimulate specific acupuncture points on the body. It has many advantages, such as warming the meridians and dispelling cold, improving blood circulation, regulating immune function, relieving pain and promoting digestion. Due to its easy operation, low price and green and natural characteristics, patients can perform moxibustion conditioning at home. However, it is difficult to objectively monitor the skin temperature during traditional moxibustion treatment, so there is a risk of burns, and the therapeutic effect of moxibustion often takes a long time to appear.

[0003] As an emerging minimally invasive drug delivery tool in the field of biomedicine, microneedle patches can effectively penetrate the epidermis and dermis of the skin to achieve efficient drug delivery. When microneedle patches are used in combination with moxibustion, the microneedles form tiny channels on the skin, which can significantly enhance the transdermal effect of drugs, thereby accelerating the time it takes for the treatment to take effect. In addition, microneedles also provide an effective heat conduction path, allowing the heat effect of moxibustion to act more fully on the target area. However, during moxibustion treatment, there are still problems with the inability to display the epidermal temperature in real time and the inability to effectively warn of the moxibustion temperature.

[0004] Therefore, based on traditional soluble microneedles, this paper proposes a drug-loaded thermochromic soluble microneedle for moxibustion treatment. While enhancing the moxibustion sensation and effect, its backing can not only prevent moxa ash from falling and burning the skin, but also serve as a means of temperature detection. When it reaches a specific temperature, it changes from colorless to red, providing an intuitive temperature indication. Patients can achieve the purpose of warning the moxibustion temperature by observing the color change of the microneedle. Summary of the invention

[0005] The purpose of the present invention is to solve the problems that moxibustion treatment is slow to take effect and the epidermal temperature cannot be displayed, and the moxibustion temperature cannot be warned. A drug-loaded thermochromic soluble microneedle for moxibustion treatment and a preparation method and application thereof are provided, so that the thermochromic material is combined with the soluble microneedle. The drug-loaded thermochromic soluble microneedle can integrate multiple functions such as drug delivery, temperature monitoring, and skin protection during moxibustion treatment, overcoming the problems that traditional moxibustion is prone to burns and cannot monitor the skin surface temperature.

[0006] To achieve the above-mentioned purpose, the present invention first provides a drug-loaded thermochromic soluble microneedle for moxibustion treatment. The drug-loaded thermochromic soluble microneedle for moxibustion is prepared by using a polyvinyl pyrrolidone solution containing a thermochromic dye as a backing solution and a drug-loaded hyaluronic acid solution as a microneedle tip solution.

[0007] In addition, the present invention also provides a method for preparing drug-loaded thermochromic soluble microneedles for moxibustion treatment, the preparation method comprising the following steps:

[0008] Step 1: Evenly mix the PDMS prepolymer and the cross-linking agent, place the master mold of the 3D printed soluble microneedle at the bottom, pour the mixture, put the mixture together with the master mold into an oven, vacuum to remove the bubbles in the mixture, and heat to solidify it; after solidification, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the conical 3D printed microneedle array template, and you can get the PDMS microneedle mold.

[0009] Step 2: Mixing a soluble polymer material polyvinyl pyrrolidone and a thermochromic dye to obtain a polyvinyl pyrrolidone solution containing a thermochromic dye, wherein the thermochromic dye changes from colorless to red at 40 degrees and gradually changes from red to colorless at temperatures below 40 degrees;

[0010] Step 3: Select appropriate drugs according to the condition, such as Chinese medicine ointment, powder or liquid such as tanshinone, and mix hyaluronic acid and the selected drugs to form a drug-loaded hyaluronic acid solution;

[0011] Step 4: The needle tip and microneedle base are made of different materials. The PDMS needle tip is filled with the drug-loaded hyaluronic acid solution in step 3, and the bubbles in the hyaluronic acid are removed by vacuum. After standing, the backing solution is filled in, and after drying, the drug-loaded thermochromic soluble microneedle for moxibustion is obtained.

[0012] Preferably, the PDMS prepolymer and the cross-linking agent described in step 1 are mixed in a volume ratio of 10:1 and allowed to stand for 20-24 minutes.

[0013] Preferably, the vacuum degree of the vacuum environment in step 1 is -0.1 MPa, and the vacuuming time is 3-5 min.

[0014] Preferably, the curing temperature in step 1 is 75-85°C and the curing time is 1-2 hours.

[0015] Preferably, the polyvinyl pyrrolidone and ultrapure water described in step 2 are mixed at a ratio of 0.3 g / ml;

[0016] Preferably, the thermochromic dye and the polyvinyl pyrrolidone aqueous solution described in step 2 are uniformly mixed at a ratio of 0.01 g / ml to prepare a polyvinyl pyrrolidone solution containing the thermochromic dye.

[0017] Preferably, the hyaluronic acid described in step three is uniformly mixed with water in a mass ratio of 1:10.

[0018] Preferably, in step three, appropriate drugs are selected according to different disease conditions, and the drugs are wrapped in the needle tip during the preparation of the needle tip module to prepare a hyaluronic acid aqueous solution containing the drug.

[0019] Preferably, the vacuum degree of the vacuum environment described in step three is -0.1 MPa, the number of vacuuming is 3-5 times, and each time lasts for 3-5 minutes.

[0020] Preferably, the standing time in step 3 is 20-60 minutes.

[0021] Preferably, the drying temperature in step 3 is 50°-70°, and the drying time is 3-4h.

[0022] Beneficial effects of the present invention

[0023] 1. The hyaluronic acid provided by the present invention as the material for preparing the soluble microneedle tip is a polymer material with good biocompatibility, biodegradability, easy solubility in water and low price.

[0024] 2. Compared with traditional microneedles, the soluble microneedles prepared in the present invention have excellent mechanical properties, can better penetrate the skin barrier, and are widely used in clinical transdermal drug delivery treatment.

[0025] 3. Compared with the traditional soluble microneedles, the microneedles prepared by the present invention are improved on the basis of the backing material of the traditional soluble microneedles, which can realize real-time monitoring of the temperature of the skin surface of the moxibustion acupoints and prevent the falling of moxa ash from burning the skin.

[0026] 4. Compared with traditional moxibustion patches, the microneedles prepared by the present invention accelerate the penetration of drugs in the skin while guiding the moxibustion heat to penetrate internally, thereby increasing the moxibustion temperature of internal tissues and enhancing the moxibustion sensation. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 (a)-(e) are schematic diagrams of the preparation process of the method for preparing drug-loaded thermochromic soluble microneedles for moxibustion according to the present invention;

[0028] Figure 2 This is a scanning electron microscope image of drug-loaded thermochromic soluble microneedles used for moxibustion therapy;

[0029] Figure 3This is an optical photograph of drug-loaded thermochromic soluble microneedles used for moxibustion therapy;

[0030] Figure 4 Schematic diagram of the structure of drug-loaded thermochromic soluble microneedles used for moxibustion treatment;

[0031] Figure 5 An exploded view of the drug-loaded thermochromic soluble microneedle structure used for moxibustion therapy;

[0032] Figure 6 A top view of drug-loaded thermochromic soluble microneedles used for moxibustion therapy;

[0033] Figure 7 Schematic diagram of the color change of drug-loaded thermochromic soluble microneedles used for moxibustion before and after heating;

[0034] Figure 8 This is a summary diagram of drug-loaded thermochromic soluble microneedles for moxibustion; DETAILED DESCRIPTION

[0035] The present invention first provides a drug-loaded thermochromic soluble microneedle for moxibustion treatment, which is prepared by using a polyvinyl pyrrolidone solution containing a thermochromic dye as a backing solution and a drug-loaded hyaluronic acid solution as a microneedle tip solution. The hyaluronic acid is a polysaccharide naturally present in human tissue, has good biocompatibility, and does not cause rejection when used. By introducing a temperature-responsive color-changing material, the user can intuitively observe whether the microneedle has reached a predetermined temperature, thereby improving the safety and effect of drug delivery.

[0036] The present invention also provides a method for preparing drug-loaded thermochromic soluble microneedles for moxibustion treatment, comprising:

[0037] Step 1: Evenly mix the PDMS prepolymer and the cross-linking agent, place the master mold of the 3D printed soluble microneedle at the bottom, pour the mixture, put the mixture together with the master mold into an oven, vacuum to remove the bubbles in the mixture, and heat to solidify it; after solidification, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the conical 3D printed microneedle array template, and you can get the PDMS microneedle mold.

[0038] Step 2: Mixing a soluble polymer material polyvinyl pyrrolidone and a thermochromic dye to obtain a soluble polymer solution containing a thermochromic dye, wherein the thermochromic dye changes from colorless to red at 40 degrees and gradually changes from red to colorless at a temperature below 40 degrees;

[0039] Step 3: Select appropriate drugs according to the condition, such as tanshinone, adenosine, and Chinese medicine ointment, and mix hyaluronic acid and the selected drugs to form a drug-loaded hyaluronic acid solution;

[0040] Step 4: The needle tip and microneedle base are made of different materials. The PDMS needle tip is filled with the drug-loaded hyaluronic acid solution in step 3, and the bubbles in the hyaluronic acid are removed by vacuum. After standing, the backing solution is filled in, and after drying, a moxibustion thermosensitive color-changing soluble microneedle patch is obtained.

[0041] The present invention also provides the use of the above-mentioned drug-loaded thermochromic soluble microneedles for moxibustion in treatment using moxibustion. Specific applications include:

[0042] First, place the microneedle at a specific acupuncture point, and fix the microneedle patch with a medical waterproof PU film. Use the thumb to press the side of the microneedle without the needle body to penetrate the stratum corneum. Under the warm effect of moxibustion, the microneedle tip quickly dissolves in the tissue fluid, and the tip can allow the moxibustion heat to penetrate into the skin, solving the problem of low moxibustion temperature in the internal tissue, weak moxibustion sensation, and low acupuncture point response during moxibustion. The thermochromic material in the backing material will gradually change from colorless to red when the skin surface temperature reaches 40°. When the skin surface temperature reaches 45 degrees, the patch will completely turn red, solving the problem of epidermal temperature not being displayed and moxibustion temperature not being able to warn during moxibustion.

[0043] After use, the microneedle backing and the needle tip can be separated, and the backing can be directly peeled off after drug administration. In addition, the microneedle tip has excellent mechanical properties and can achieve rapid drug release after piercing the skin.

[0044] The present invention is described in more detail below in conjunction with the accompanying drawings and embodiments, but the present invention is not limited thereto. For those skilled in the art, several improvements and modifications can be made without departing from the technical principles of the present invention, and these improvements and modifications are also considered to be within the scope of protection of the present invention. The contents not described in detail in this specification belong to the prior art known to professional and technical personnel in the field.

[0045] Embodiment 1:

[0046] Mix the PDMS prepolymer and the cross-linking agent in a volume ratio of 10:1 and let stand for 20-30 minutes to mix evenly. Place the 3D printed soluble microneedle master mold at the bottom, pour in the evenly mixed PDMS, put the PDMS and the master mold into the oven, evacuate to -0.1MPa to remove the bubbles, and then heat at 75-85℃ for 1-2 hours to solidify the PDMS. After the PDMS is solidified, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the conical 3D printed microneedle array template, and you can get the PDMS microneedle array template.

[0047] Weigh 1.50g of polyvinyl pyrrolidone particles, dissolve them evenly in 5ml of deionized water, mix and stir them evenly at 200rpm / min for 0.5-1h to prepare a polyvinyl pyrrolidone solution with a concentration of 0.3g / ml; weigh 0.05g of thermochromic dye and dissolve it evenly in 5ml of polyvinyl pyrrolidone solution to prepare a polyvinyl pyrrolidone solution containing thermochromic dye with a concentration of 0.01g / ml; weigh 0.40g of hyaluronic acid and dissolve it evenly in 4ml of deionized water to prepare a hyaluronic acid aqueous solution with a concentration of 0.1g / ml; weigh 0.004g of tanshinone drug and dissolve it evenly in 4ml of hyaluronic acid aqueous solution, mix and stir it at 200rpm / min for 30min to obtain a hyaluronic acid aqueous solution containing tanshinone (0.1% (w / v)) as a microneedle tip solution.

[0048] Take 15μL of microneedle tip solution and pour it into the tip part of the PDMS microneedle mold, evacuate to -0.1Mpa, evacuate 3-5 times, each time for 3-5 minutes, and then let it stand for 20-60 minutes; then fill in 2ml of backing solution, dry at 50°-70°, and dry for 3-4h. After standing and drying, take it out of the mold to obtain a drug-loaded thermosoluble microneedle protective patch for combined moxibustion.

[0049] Embodiment 2:

[0050] Mix the PDMS prepolymer and the cross-linking agent in a volume ratio of 10:1 and let stand for 20-30 minutes to mix evenly. Place the 3D printed soluble microneedle master mold at the bottom, pour in the evenly mixed PDMS, put the PDMS and the master mold into the oven, evacuate to -0.1MPa to remove the bubbles, and then heat at 75-85℃ for 1-2 hours to solidify the PDMS. After the PDMS is solidified, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the conical 3D printed microneedle array template, and you can get the PDMS microneedle array template.

[0051] Weigh 1.50g of polyvinyl pyrrolidone particles, dissolve them evenly in 5ml of deionized water, mix and stir them evenly at 200rpm / min for 0.5-1h to prepare a polyvinyl pyrrolidone solution with a concentration of 0.3g / ml. Weigh 0.05g of thermochromic dye and dissolve them evenly in 5ml of polyvinyl pyrrolidone solution to prepare a polyvinyl pyrrolidone solution containing thermochromic dye with a concentration of 0.01g / ml. Weigh 0.40g of hyaluronic acid and dissolve them evenly in 4ml of deionized water to obtain a hyaluronic acid aqueous solution with a concentration of 0.1g / ml; weigh 0.04g of tanshinone drug and add it to 4ml of hyaluronic acid aqueous solution, mix and stir it at 200rpm / min for 30min to obtain a hyaluronic acid aqueous solution containing the drug (1% (w / v)) as the microneedle tip solution.

[0052] Take 15μL of microneedle tip solution and pour it into the tip part of the PDMS microneedle mold, evacuate to -0.1Mpa, evacuate 3-5 times, each time for 3-5 minutes, and then let it stand for 20-60 minutes; then fill in 2ml of backing solution, dry at 50°-70°, and dry for 3-4h. After standing and drying, take it out of the mold to obtain a drug-loaded thermosoluble microneedle protective patch for combined moxibustion.

[0053] Embodiment 3:

[0054] Mix the PDMS prepolymer and the cross-linking agent in a volume ratio of 10:1 and let stand for 20-30 minutes to mix evenly. Place the 3D printed soluble microneedle master mold at the bottom, pour in the evenly mixed PDMS, put the PDMS and the master mold into the oven, evacuate to -0.1MPa to remove the bubbles, and then heat at 75-85℃ for 1-2 hours to solidify the PDMS. After the PDMS is solidified, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the conical 3D printed microneedle array template, and you can get the PDMS microneedle array template.

[0055] Weigh 1.50g of polyvinyl pyrrolidone particles, dissolve them evenly in 5ml of deionized water, mix and stir them evenly at 200rpm / min for 0.5-1h to prepare a polyvinyl pyrrolidone solution with a concentration of 0.3g / ml. Weigh 0.05g of thermochromic dye and dissolve them evenly in 5ml of polyvinyl pyrrolidone solution to prepare a polyvinyl pyrrolidone solution containing thermochromic dye with a concentration of 0.01g / ml. Weigh 0.40g of hyaluronic acid and dissolve them evenly in 4ml of deionized water to obtain a hyaluronic acid aqueous solution with a concentration of 0.1g / ml; weigh 0.2g of tanshinone drug and add it to 4ml of hyaluronic acid aqueous solution, mix and stir it at 200rpm / min for 30min to obtain a hyaluronic acid aqueous solution containing the drug (5% (w / v)) as the microneedle tip solution.

[0056] Take 15μL of microneedle tip solution and pour it into the tip part of the PDMS microneedle mold, evacuate to -0.1Mpa, evacuate 3-5 times, each time for 3-5 minutes, and then let it stand for 20-60 minutes; then fill in 2ml of backing solution, dry at 50°-70°, and dry for 3-4h. After standing and drying, take it out of the mold to obtain a drug-loaded thermosoluble microneedle protective patch for combined moxibustion.

[0057] Before use, disinfect the skin. Stick the prepared drug-loaded thermochromic soluble microneedles on the acupuncture points to be moxibustioned, and fix the microneedle patch with a waterproof PU film. Perform moxibustion treatment while observing the color change of the microneedle backing. When the backing changes color, it indicates that the skin temperature has reached the predetermined temperature, and the color change is used to visually warn the user to avoid burns. After the microneedles dissolve, the drug is released into the skin to exert a therapeutic effect.

[0058] Through the method of the above embodiment, the present invention provides a safe, efficient and convenient drug-loaded thermochromic soluble microneedle for moxibustion treatment, which solves the problem of temperature monitoring failure and easy burns in traditional moxibustion operations, and realizes efficient drug delivery and real-time temperature monitoring.

Claims

1. A drug-loaded thermochromic soluble microneedle for moxibustion treatment, characterized in that: The drug-loaded thermochromic soluble microneedle is prepared by using a polyvinyl pyrrolidone solution containing a thermochromic dye as a backing solution and a hyaluronic acid solution loaded with tanshinone as a microneedle tip solution.

2. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 1, characterized in that: The preparation method comprises the following steps: Step 1: Evenly mix the PDMS prepolymer and the cross-linking agent, place the 3D printed microneedle master mold at the bottom, pour in the mixture, put the mixture together with the master mold into an oven, vacuum to remove the bubbles in the mixture, and heat to solidify it; after solidification, take it out of the oven, cool it to room temperature, separate the solidified PDMS from the 3D printed microneedle master mold, and you can get the PDMS microneedle mold. Step 2: Evenly mix the soluble polymer material polyvinyl pyrrolidone and the thermochromic dye to obtain a polyvinyl pyrrolidone solution containing the thermochromic dye as a backing solution, wherein the thermochromic dye gradually changes from colorless to red at 40 degrees, and gradually changes from red to colorless at temperatures below 40 degrees; Step 3: Select appropriate drugs according to the condition, such as Chinese medicine ointment, powder or liquid such as tanshinone, and mix hyaluronic acid and the selected drugs to form a drug-loaded hyaluronic acid solution; Step 4: The needle tip and microneedle base are made of different materials. The PDMS needle tip is filled with the drug-loaded hyaluronic acid solution in step 3, and the bubbles in the hyaluronic acid are removed by vacuum. After standing, the backing solution is filled in, and after drying, the drug-loaded thermochromic soluble microneedle for moxibustion treatment is obtained.

3. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The PDMS prepolymer and the cross-linking agent described in step 1 are mixed in a volume ratio of 10:1 and allowed to stand for 20-24 minutes.

4. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The vacuum degree of the vacuum environment in step 1 is -0.1 MPa, and the vacuuming time is 3-5 min.

5. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The curing temperature in step 1 is 75-85° C. and the curing time is 1-2 hours.

6. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The polyvinyl pyrrolidone and deionized water described in step 2 are mixed in a mass ratio of 3:

10.

7. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The thermochromic dye and the polyvinyl pyrrolidone aqueous solution described in step 2 are uniformly mixed in a mass ratio of 1:100 to prepare a polyvinyl pyrrolidone solution containing the thermochromic dye.

8. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The mixing condition of the polyvinyl pyrrolidone solution containing the thermochromic dye in step 2 is uniformly mixing at 200-400 rpm / min at room temperature for 0.5-1 h.

9. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The hyaluronic acid described in step 3 is evenly mixed with deionized water in a mass ratio of 1:

10.

10. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: In step three, appropriate drugs are selected according to different conditions and added to the hyaluronic acid aqueous solution to prepare the drug-containing hyaluronic acid aqueous solution.

11. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The vacuum degree of the vacuum environment in step 4 is -0.1Mpa, the number of vacuuming is 3-5 times, and each time lasts for 3-5 minutes.

12. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The standing time in step 4 is 20-60 minutes.

13. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: The drying temperature in step 4 is 50°-70°, and the drying time is 3-4h.

14. The method for preparing a drug-loaded thermochromic soluble microneedle for moxibustion treatment according to claim 2, characterized in that: During moxibustion treatment, the burning moxa stick is suspended 2-3 cm from the skin and moved back and forth or hovered on the drug-loaded thermochromic soluble microneedles. The thermochromic dye will change from colorless to red at 40 degrees. By observing the color change of the microneedles, the temperature change of the moxibustion site is monitored, and the wrapped drug is delivered to the target site through the hyaluronic acid needle tip.

15. Application of drug-loaded thermochromic soluble microneedles for moxibustion therapy.